J5V-22875-77291
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 550 / MN
- Registered
- 2021-08-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-13
Dose 1 — Pfizer-BioNTech
-
2021-08-28
Registered in v-safe
- 2021-08-28
- 2021-09-03
-
2021-09-04
Dose 2 — Pfizer-BioNTech
-
2021-09-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-09-09
-
2021-09-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-09-11
- 2021-09-25
- 2021-10-02
- 2021-10-09
- 2021-10-17
-
2021-12-04
Survey response — 3 months, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Migraines 3-5 times a weekMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-07
Call successfulDoes not wish to fill out VAERS report
- 2022-03-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-13 | Pfizer-BioNTech | No |
| 2 | 2021-09-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 3 months, dose 2
Symptoms: Migraines 3-5 times a week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release